Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Thyroid hormone receptor α in skeletal muscle is essential for T3-mediated increase in energy expenditure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Influence of FGF23 and Klotho on male reproduction: Systemic vs direct effects

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Preserved capacity for satellite cell proliferation, regeneration, and hypertrophy in the skeletal muscle of healthy elderly men

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prenatal inflammation suppresses blood Th1 polarization and gene clusters related to cellular energy metabolism in preterm newborns

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lectin complement pathway initiators after subarachnoid hemorrhage - an observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Local complement activation is associated with primary graft dysfunction after lung transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Dysregulation of the complement system is involved in the pathogenesis of several diseases, and its inhibition has been shown to be a feasible therapeutic option. Therefore, there is an interest in the development of complement modulators to treat complement activation-related inflammatory pathologies. Mannose-binding lectin (MBL)/ficolin/collectin-associated protein-1 (MAP-1) is a regulatory molecule of the lectin pathway (LP), whereas complement receptor 1 (CD35) and decay-accelerating factor (CD55) are membrane-anchored regulators with effects on the central effector molecule C3. In this study, we developed 2 novel soluble chimeric inhibitors by fusing MAP-1 to the 3 first domains of CD35 (CD351-3) or the 4 domains of CD55 (CD551-4) to modulate the complement cascade at 2 different stages. The constructs showed biologic properties similar to those of the parent molecules. In functional complement activation assays, the constructs were very efficient in inhibiting LP activation at the level of C3 and in the formation of terminal complement complex. This activity was enhanced when coincubated with recombinant LP recognition molecules MBL and ficolin-3. Recombinant MAP-1 fusion proteins, combined with recombinant LP recognition molecules to target sites of inflammation, represent a novel and effective therapeutic approach involving the initiation and the central and terminal effector functions of the complement cascade.-Pérez-Alós, L., Bayarri-Olmos, R., Skjoedt, M.-O., Garred, P. Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade.

Original languageEnglish
JournalFASEB Journal
Volume33
Issue number11
Pages (from-to)12723-12734
ISSN0892-6638
DOIs
Publication statusPublished - Nov 2019

    Research areas

  • chimeric proteins, complement regulation, lectin pathway, MASPs, RCA family

ID: 58007557